Skip to main content
. 2020 Nov 25;16(1):1–13. doi: 10.1515/med-2021-0004

Figure 4.

Figure 4

Analysis of ZG16B expression patterns in breast cancer patients with different clinical-pathologic features. Ualcan analysis showed the mRNA expression level of ZG16B in breast cancer patients with distinct gender (a), age (b), cancer stages (c), node metastasis status (d), and molecular subtypes (e). Asterisks were marked to show the significance of each breast cancer group compared with normal group (*p < 0.05, **p < 0.01, ***p < 0.001).